AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 11697808
Drug: 0.50 microg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.50 microg/day of calcitriol and 500 mg/day of calcium carbonate
Trial: 9329411
Drug: Hydrophilic gel
RxNorm normalized name: PSYLLIUM HYDROPHILIC MUCILLOID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrophilic gel
Trial: 7608850
Drug: Amoxicillin/clavulanate potassium
RxNorm normalized name: Amoxicillin/Clavulanate Potassium 250 MG-125 MG Oral Tablet
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanate potassium during the first 10 post-operative days
Trial: 19073976
Drug: Aspirin (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (600 mg per day)
Trial: 19073976
Drug: Placebo (for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (for aspirin group)
Trial: 19073976
Drug: Resistant starch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resistant starch (30 g per day)
Trial: 15662112
Drug: Oral suspension
RxNorm normalized name: Oral Suspension
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral suspension of granisetron (2 mg) and dexamethasone (16 mg for highly emetogenic chemotherapy, 4 mg for moderately emetogenic chemotherapy)
Trial: 12662126
Drug: Rituximab 375
RxNorm normalized name: Rituximab
DrugBank: Rituximab (DB00073)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Rituximab 375 mg/m(2) intravenously once weekly for 4 weeks
Trial: 3897296
Drug: Aspirin 300
RxNorm normalized name: aspirin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 300 mg
Trial: 2079176
Drug: Conservative modified
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative modified MO and DO preparations with glass-ionomer liner
Trial: 2079176
Drug: Conventional MO
RxNorm normalized name: Mineral Oil
DrugBank: Mineral oil (DB11057)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional MO and DO preparations with glass-ionomer liner
Trial: 2079176
Drug: Conservative modified
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative modified MO and DO preparations with calcium hydroxide liner
Trial: 340333
Drug: Cimetidine, 300
RxNorm normalized name: Cimetidine, 300 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine, 300 mg four times daily
Trial: 12121503
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg b.i.d. with amoxicillin 500 mg t.i.d. and clarithromycin 200 mg t.i.d.
Trial: 12121503
Drug: Lansoprazole 30
RxNorm normalized name: lansoprazole 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole 30 mg b.i.d. with amoxicillin 500 mg t.i.d. and clarithromycin 200 mg t.i.d.
Trial: 12121503
Drug: Rabeprazole 10
RxNorm normalized name: RABEprazole 10 mg oral delayed release tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole 10 mg b.i.d. with amoxicillin 500 mg t.i.d. and clarithromycin 200 mg t.i.d.
Trial: 29482528
Drug: Saxagliptin monotherapy
RxNorm normalized name: Saxagliptin
DrugBank: Saxagliptin (DB06335)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saxagliptin monotherapy
Trial: 29482528
Drug: Saxagliptin, metformin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saxagliptin, metformin, and combination treatment
Trial: 29482528
Drug: Saxagliptin and
RxNorm normalized name: saxagliptin and dapagliflozin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saxagliptin and metformin treatments
Trial: 22409966
Drug: Nasal antiseptic
RxNorm normalized name: 3M Skin and Nasal Antiseptic
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nasal antiseptic ointment (oxytetracycline hydrochloride‐polymyxin B sulfate)
Trial: 19100932
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg of ondansetron (Group O)
Trial: 19100932
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg of ondansetron plus 20 mg of prochlorperazine (Group OP)
Trial: 12771740
Drug: Intracavernous injection
RxNorm normalized name: Bivalirudin 250 mg INTRACAVERNOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracavernous injection of 20 mg prostaglandin E1 within the first 3 months (group 1)
Trial: 12771740
Drug: Intracavernous injection
RxNorm normalized name: Bivalirudin 250 mg INTRACAVERNOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracavernous injection of 20 mg prostaglandin E1 at 4 to 12 months (group 2)
Trial: 8844449
Drug: Orlistat 120
RxNorm normalized name: orlistat 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orlistat 120 mg three times a day for 7 days
Trial: 1385902
Drug: Methylprednisolone (Depo‐Medrol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (Depo‐Medrol 80 mg/ml)
Trial: 1385902
Drug: Bupivacaine (Marcaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine (Marcaine .5% 1.5 ml)
Trial: 6734028
Drug: 400 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 micrograms fenoterol by metered dose inhaler four times a day
Trial: 15644588
Drug: Atorvastatin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (10 mg/day)
Trial: 22900989
Drug: Pitavastatin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pitavastatin (2 mg/day) for 6 months
Trial: 19858319
Drug: Transdermal TPTD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal TPTD patch (20, 30, or 40-microg)
Trial: 19858319
Drug: Transdermal TPTD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal TPTD 40-microg patch
Trial: 19858319
Drug: All treatment
RxNorm normalized name: UNDECYLENIC ACID 8 g in 30 mL / TOLNAFTATE 1 g in 30 mL TOPICAL LIQUID [Fugal nall treatment]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All treatment groups (including transdermal TPTD and TPTD injection)
Trial: 18662492
Drug: Duloxetine 60
RxNorm normalized name: duloxetine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine 60 mg QD
Trial: 2179038
Drug: Cetacaine topical
RxNorm normalized name: Cetacaine Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetacaine topical anesthetic spray preparation
Trial: 7363933
Drug: Disopyramide capsules
RxNorm normalized name: disopyramide Oral Capsule
DrugBank: Disopyramide (DB00280)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Disopyramide capsules 150 mg every 6 h for five days
Trial: 7363933
Drug: Controlled-release tablets
RxNorm normalized name: Afeditab CR
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Controlled-release tablets
Trial: 7363933
Drug: Disopyramide capsules
RxNorm normalized name: disopyramide Oral Capsule
DrugBank: Disopyramide (DB00280)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Disopyramide capsules
Trial: 31442618
Drug: Lifestyle and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lifestyle and occupational exposures (including age, BMI, cigarette smoking, regular exercise, daily vehicle vibration)
Trial: 22420645
Drug: Combined spinal-epidural
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined spinal-epidural (CSE) with intrathecal bupivacaine 2.5 mg and fentanyl 5 μg
Trial: 22420645
Drug: Epidural with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural with bupivacaine 20 mg and fentanyl 40 μg
Trial: 17895472
Drug: High-dose sorafenib
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose sorafenib
Trial: 11384572
Drug: Sildenafil citrate
RxNorm normalized name: Sildenafil Citrate
DrugBank: Sildenafil (DB00203)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sildenafil citrate (100 mg)
Trial: 9880383
Drug: Clomethiazole (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomethiazole (75 mg/kg)
Trial: 28817997
Drug: Cladribine 3.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cladribine 3.5 mg/kg
Trial: 25157992
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy and surgery (case group)
Trial: 22257503
Drug: Constraint-induced movement
RxNorm normalized name: constant albicans extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Constraint-induced movement therapy
Trial: 17487652
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg 17beta‐estradiol (E2) + 0.25 mg norethisterone acetate (NETA)
Trial: 17487652
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg E2 + 0.1 mg NETA
Trial: 9635933
Drug: Salmeterol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol (50 microg twice daily for 3 weeks)
Trial: 9635933
Drug: Budesonide (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide (200 microg twice daily for 3 weeks)
Trial: 3275894
Drug: Nimodipine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimodipine (30 mg every six hours)
Trial: 849673
Drug: Thioridazine (high
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thioridazine (high dose)
Trial: 849673
Drug: Thioridazine (low
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thioridazine (low dose)
Trial: 849673
Drug: Thioridazine (high
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thioridazine (high and low doses)
Trial: 22208805
Drug: Oxymorphone ER
RxNorm normalized name: oxymorphone Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxymorphone ER 40 mg with 240 mL of ethanol 20%
Trial: 22208805
Drug: Oxymorphone CRF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxymorphone CRF 40 mg with 240 mL of ethanol 40%
Trial: 10899655
Drug: Sequential methotrexate
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Sequential methotrexate and 5-fluorouracil (MF)
Trial: 8523236
Drug: D-[U-13C]glucose (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-[U-13C]glucose (100 mg/kg)
Trial: 8523236
Drug: Intravenous 10%
RxNorm normalized name: fat emulsion, intravenous 10% intravenous emulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous 10% dextrose (D10W)
Trial: 17261652
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg clopidogrel daily maintenance dose
Trial: 7874944
Drug: Limited pulmonary
RxNorm normalized name: Lobaria pulmonaria extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Limited pulmonary rehabilitation program focused on coping strategies for shortness of breath (6-week treatment)
Trial: 2571815
Drug: Psychosocial intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Psychosocial intervention (weekly supportive group therapy with self-hypnosis for pain)
Trial: 930916
Drug: Total duration
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total duration of oral contraceptive use
Trial: 25041550
Drug: Non-surgical mechanical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-surgical mechanical periodontal treatment (test group, n = 32)
Trial: 20180933
Drug: Crushed tablets
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crushed tablets with concomitant meal
Trial: 20180933
Drug: Dispersible tablets
RxNorm normalized name: Disperse Blue 106
DrugBank: Disperse Blue 106 (DB14203)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dispersible tablets with concomitant meal
Trial: 20180933
Drug: Crushed tablets
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crushed tablets with milk
Trial: 20180933
Drug: Dispersible tablets
RxNorm normalized name: Disperse Blue 106
DrugBank: Disperse Blue 106 (DB14203)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dispersible tablets with milk
Trial: 18288237
Drug: Lactobacillus crispatus
RxNorm normalized name: LACTOBACILLUS CRISPATUS
DrugBank: Lactobacillus crispatus strain CTV-05 (DB19093)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus crispatus CTV‐05 vaginal suppository
Trial: 29943384
Drug: Placebo vaginal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo vaginal suppository
Trial: 12419098
Drug: Pemirolast potassium
RxNorm normalized name: Pemirolast Potassium
DrugBank: Pemirolast (DB00885)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pemirolast potassium 0.1% ophthalmic solution
Trial: 9860152
Drug: Olanzapine 10
RxNorm normalized name: olanzapine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine 10 mg alone
Trial: 9860152
Drug: Olanzapine 10
RxNorm normalized name: olanzapine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine 10 mg after 2 weeks of carbamazepine 200 mg BID
Trial: 897864
Drug: L-leucine therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-leucine therapy
Trial: 897864
Drug: Single loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single loading doses of L-kynurenine
Trial: 31079282
Drug: Aromatase inhibitors
RxNorm normalized name: Aromatase inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aromatase inhibitors (AIs) - Exemestane and Letrozole
Trial: 27472858
Drug: Hot-pack +
RxNorm normalized name: Red Hot
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hot-pack + laser therapy 1 (850 nm Ga-Al-As laser)
Trial: 27472858
Drug: Hot-pack +
RxNorm normalized name: Red Hot
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hot-pack + laser therapy 2 (650 nm He-Ne, 785 ve 980 nm Ga-Al-As combined plaque laser)
Trial: 18276744
Drug: Alendronate 5
RxNorm normalized name: ALENDRONATE 5MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate 5 mg/day for 2 years followed by 10 mg/day for 1 year
Trial: 17013567
Drug: Teriparatide 20
RxNorm normalized name: TERIPARATIDE 200UNT/VIL INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Teriparatide 20 mcg/day
Trial: 17013567
Drug: Teriparatide 40
RxNorm normalized name: Teriparatide
DrugBank: Teriparatide (DB06285)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Teriparatide 40 mcg/day
Trial: 14624219
Drug: Misoprostol as
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Misoprostol as a single agent
Trial: 11192134
Drug: Clarithromycin extended-release
RxNorm normalized name: Clarithromycin Extended-Release Tablets
DrugBank: Clarithromycin (DB01211)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clarithromycin extended-release (once-daily for 14 days)
Trial: 11192134
Drug: Clarithromycin immediate-release
RxNorm normalized name: clarithromycin Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin immediate-release (twice-daily for 14 days)
Trial: 11192133
Drug: Clarithromycin immediate-release
RxNorm normalized name: clarithromycin Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin immediate-release
Trial: 9201523
Drug: S. boulardii
RxNorm normalized name: Lactobac. plantarum/S. boulardii/Pediococcus acidilactici 8 billion cell ORAL CAPSULE,DELAYED RELEASE (ENTERIC COATED)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S. boulardii 500 mg four times a day
Trial: 9201523
Drug: S. boulardii
RxNorm normalized name: Lactobac. plantarum/S. boulardii/Pediococcus acidilactici 8 billion cell ORAL CAPSULE,DELAYED RELEASE (ENTERIC COATED)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S. boulardii 500 mg four times a day (after adjustment for risk factors)
Trial: 7835781
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no hormonal treatment)
Trial: 2972171
Drug: Danazol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danazol (200 mg, 3 times daily)
Trial: 2972171
Drug: High-dose Medroxyprogesterone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose Medroxyprogesterone Acetate (MPA) (100 mg daily)
Trial: 12799617
Drug: Atypical antipsychotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atypical antipsychotics (risperidone, clozapine, olanzapine, quetiapine)
Trial: 10513172
Drug: Lactated Ringer's
RxNorm normalized name: LACTATED RINGER'S
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lactated Ringer's solution (LR group, n = 10)
Trial: 10513172
Drug: Acetated Ringer's
RxNorm normalized name: ACETATED RINGER'S
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetated Ringer's solution (AR group, n = 10)
Trial: 27513296
Drug: Supervised exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supervised exercise therapy (SET)
Trial: 23826157
Drug: Pharmacological treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacological treatment for 12 weeks
Trial: 17361345
Drug: Albuterol (sustained-release,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol (sustained-release, 8 mg bid)
Trial: 9238064
Drug: Lupron alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lupron alone (gonadotropin-releasing hormone agonist)
Trial: 8116741
Drug: 5-fluorouracil (five
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-fluorouracil (five injections of 5 mg during two weeks after surgery)
Trial: 28068186
Drug: PDT+chitosan 3 mg/mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PDT+chitosan 3 mg/mL
Trial: 24351694
Drug: Midazolam (doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (doses of at least 0.3 mg/kg)
Trial: 24351694
Drug: Midazolam (any
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (any dose)
Trial: 12707092
Drug: Daily sunscreen
RxNorm normalized name: ZINC OXIDE 220 mg in 1 mL TOPICAL CREAM [SPF 30 Daily Sunscreen]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily sunscreen application (high-protection sunscreen applied every morning)
Trial: 12707092
Drug: Beta carotene
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta carotene supplementation (30 mg/day)
Trial: 1568574
Drug: Immediate start
RxNorm normalized name: Star Anise Oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate start of steroid tapering (group A; n = 46)
Trial: 1568574
Drug: Continued prednisolone
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continued prednisolone treatment for 5 more weeks before tapering (group B; n = 50)
Trial: 6232035
Drug: Etodolac, 1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etodolac, 1200 mg/day
Trial: 6232035
Drug: Aspirin, 2600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin, 2600 mg/day
Trial: 29408818
Drug: Conventional restorative
RxNorm normalized name: DRESSING,RESTORE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional restorative treatment (CRT)
Trial: 17378909
Drug: Somatostatin 250
RxNorm normalized name: Somatostatine
DrugBank: Somatostatin (DB09099)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Somatostatin 250 microg/h continuous IV infusion for 48 h after a bolus of 250 microg
Trial: 17378909
Drug: Somatostatin 250
RxNorm normalized name: Somatostatine
DrugBank: Somatostatin (DB09099)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Somatostatin 250 microg/h continuous IV infusion for 48 h
Trial: 15972934
Drug: Low toenail
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low toenail chromium concentration (average 1.10 mug/g in cases)
Trial: 15972934
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (average toenail chromium concentration 1.30 mug/g)
Trial: 30300054
Drug: Blood flow
RxNorm normalized name: NITRIC OXIDE 400 mg in 500 mg TOPICAL CAPSULE [Bio NO Brain Care (Helps improve Brain blood flow and body temperature, Fermented Garlic powder)]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood flow restriction (BFR) therapy combined with low-resistance muscular training for 15 weeks
Trial: 30300054
Drug: Blood flow
RxNorm normalized name: NITRIC OXIDE 400 mg in 500 mg TOPICAL CAPSULE [Bio NO Brain Care (Helps improve Brain blood flow and body temperature, Fermented Garlic powder)]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood flow restriction (BFR) therapy combined with low-resistance muscular training for 13 days
Trial: 22832470
Drug: Error-augmentation training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Error-augmentation training
Trial: 17031007
Drug: Chitosan (six
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chitosan (six 500 mg capsules per day)
Trial: 13678871
Drug: Candesartan (32
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan (32 mg once daily)
Trial: 11051260
Drug: Docetaxel 70
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel 70 mg/m2 followed by Doxorubicin 50 mg/m2
Trial: 11051260
Drug: Doxorubicin 50
RxNorm normalized name: DOXOrubicin 50 mg intravenous powder for injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxorubicin 50 mg/m2 followed by Docetaxel 60 mg/m2
Trial: 8266157
Drug: Lignocaine spray
RxNorm normalized name: lidocaine Mucosal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lignocaine spray
Trial: 9176438
Drug: Lignocaine spray
RxNorm normalized name: lidocaine Mucosal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lignocaine spray and Placebo
Trial: 3568540
Drug: Ketorolac 90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac 90 mg
Trial: 3568540
Drug: Morphine 12
RxNorm normalized name: morphine 120 mg/24 hours oral capsule, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 12 mg
Trial: 9283163
Drug: Morphine 6
RxNorm normalized name: apomorphine 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 6 mg